By Patricia Reaney
LONDON (Reuters) - An active ingredient in cannabis can ease inflammation and slow the progression of coronary artery disease in mice, and possibly humans, researchers said on Wednesday.
Daily low doses of the ingredient, THC, prevented atherosclerosis, a primary cause of heart disease and stroke in western countries, without producing the associated high.
"We have proven that very low doses of cannabis therapy will have an anti-inflammatory effect that will slow the progression of atherosclerosis in mice," said Dr Francois Mach, of Geneva University Hospital in Switzerland.
He and his team do not know whether TCH, or delta-9-tetrahydrocannabinol, will have the same effect in humans. But they believe the discovery will help find compounds that produce the same effect in humans without side effects such as raised blood pressure or euphoria.
More